Professor Roger Steinert
Ophthalmic surgeons now have some good options for presbyopia surgery. Choosing among them is critical in achieving happy patients. Analyzing and improving unhappy postoperative patients is equally important. New technology on the horizon will continue the quest for uniformly excellent results.
COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY